4536 — SANTEN PHARMACEUTICAL Share News
0.000.00%
Last trade - 00:00- ¥558bn
- ¥537bn
- ¥292bn
Bought Back 4.05 Million Own Shares Worth 6.44 Billion Yen Between May 10 And May 31
To Buy Back Up To 5.8% Of Shares Worth 38 Billion Yen
Table: Santen Pharm -2023/24 parent results
Table: Santen Pharm -2023/24 group results (IFRS)
Filing
To Retire Treasury Shares Worth 3.2% Of Outstanding Stock On March 29
Table: Santen Pharm -9-MTH group results (IFRS)
Announces Result Of Share Buyback For December
Table: Santen Pharm -6-MTH group results (IFRS)
Brief: Santen Pharmaceutical Co Ltd Announces Result Of Share Buyback For October
Bought Back 523,400 Own Shares Worth 722.6 Million Yen In Sept
Table: Santen Pharm -2023/24 group forecast(IFRS)
Announces Result Of Share Buyback For August
Table: Santen Pharm -Q1 group results (IFRS)
Harrow Health rises on separate deals for eye disease drugs, Q2 rev forecast
Advisory: Alerts on pharma companies wrongly tagged to Visa withdrawn
Brief: Santen Pharmaceutical Says Agreement With Visiox Pharmaceuticals On Rights To Product Manufacturing, Commercialization, And Sales Of Omlonti
Announces Result Of Share Buyback For June
Announces Result Of Share Buyback Between May 12-31